[1]
|
[1]WANG M, SUN G B, ZHANG J Y, et al.Elatoside C protects the heart from ischaemia/reperfusion injury through the modulation of oxidative stress and intracellular Ca2+homeostasis[J].Int J Cardiol, 2015, 185 (2) :167-176.
|
[2]
|
[2]GROVER-PAEZ F, ZAVALZA-GMEZ AB.Endothelial dysfunction and cardiovascular risk factors[J].Diabetes Res Clin Pract, 2009, 84 (1) :1-10.
|
[3]
|
[3]MARX N, GRANT P J.Endothelial dysfunction and cardiovascular disease the lull before the storm[J].Diab Vasc Dis Res, 2007, 4 (2) :82-83.
|
[4]
|
[4]STEINBERG S F.Structural basis of protein kinase C isoform function[J].Physiol Rev, 2008, 88 (4) :1341-1378.
|
[5]
|
[5]LAI L, ZHANG X, ZHANG X, et al.Lazaroid U83836E protects the heart against ischemia reperfusion injury via inhibition of oxidative stress and activation of PKC[J].Mol Med Rep 2016, 13 (1) :3993-4000.
|
[6]
|
[6]AKITA Y.Protein kinase C-epsilon (PKC-epsilon) :Iits unique structure and function[J].J Biochem, 2002, 132 (6) :847-852.
|
[7]
|
[7]CHEN Y, TIAN Q.The role of protein kinase C epsilon in neural signal transduction and neurogenic diseases[J].Front Med, 2011, 5 (1) :70-76.
|
[8]
|
[8]HUND T J, LERNER D L, YAMADA K A, et al.Protein kinase Cepsilon mediates salutary effects on electrical coupling induced by ischemic preconditioning[J].Heart Rhythm, 2007, 4 (9) :1183-1193.
|
[9]
|
[9]INAGAKI K, CHURCHILL E, MOCHLY-ROSEN D.Epsilon protein kinase C as a potential therapeutic target for the ischemic heart[J].Cardiovas Res, 2006, 70 (15) :222-230.
|
[10]
|
[10]HAO Z, PAN S S, SHEN Y J, et al.Exercise preconditioning-induced early and late phase of cardioprotection is associated withprotein kinase C epsilon translocation[J].Circ J, 2014, 78 (7) :1636-1645.
|
[11]
|
[11]TANG L, PENG Y, XU T, et al.The effects of quercetin protect cardiomyocytes from A/R injury is related to its capability to increasing expression and activity of PKC epsilon protein[J].Mol Cell Biochem, 2013, 382 (1) :145-152.
|
[12]
|
[12]LIN L L, LIU A J, LIU J G, et al.Protective effects of scutellarin and breviscapine on brain and heart ischemia in rats[J].J Cardiovasc Pharmacol, 2007, 50 (1) :327-332.
|
[13]
|
[13]ZHANG H F, HU X M, WANG L X, et al.Protective effects of scutellarin against cerebral ischemia in rats:evidence for inhibition of the apoptosis-inducing factor pathway[J].Planta Med, 2009, 75 (1) :121-126.
|
[14]
|
[14]XIAOHUA D U, CHEN CHEN, MIN ZHANG, et al.Scutellarin reduces endothelium dysfunction through the PKG-I pathway[J].Evidence-Based Complementary and Alternative Medicine, 2015, 2015 (1) :1-12.
|
[15]张人伟, 张元玲, 王杰生.灯盏花黄酮类成分的分离鉴定[J].中草药, 1988, 19 (5) :7-9.
|
[16]朱君荣, 李运曼.灯盏花素冰片注射液对实验性脑缺血的保护作用[J].中国药科大学学报, 2007, 38 (5) :456-460.
|
[17]
|
[17]YANG W, LUST R M, BOFFERDING A, et al.Nitric oxide and catalase-sensitive relaxation by scutellarin in the mouse thoracic aorta[J].J Cardiovasc Pharmacol, 2009, 53 (1) :66-76.
|
[18]杨翼, 李章华, 石武谛, 等.热预处理对超负荷训练大鼠心肌蛋白激酶C表达的影响[J].中国康复理论与实践, 2015, 21 (1) :49-53.
|
[19]
|
[19]KORZICK D H, RISHEL ME, BOWLES D K.Exercise and hypercholesterolemia produce disparate shifts in coronary PKC expression[J].Med Sci Sports Exerc, 2005, 37 (3) :381-388.
|